|
|
|
14.08.26 - 15:48
|
ANLEIHEN-Woche #KW33 – 2026: PANDION, Photon Energy, Homann Holzw., Energiekontor, PNE, EverYield, Multitude, Singulus, Eleving, Score Capital, Formycon, LAIQON, ABO Energy, BENO, … (Anleihen-Finder)
|
|
|
Angespannte Lage am KMU-Anleihemarkt Die PANDION AG hat zu Beginn der Kalenderwoche 33 einen Insolvenzantrag in Eigenverwaltung gestellt. Hintergrund ist die angespannte Liquiditätssituation der Gesellschaft […]
Der Beitrag ANLEIHEN-Woche #KW33 – 2026: PANDION, Photon Energy, Homann Holzw., Energiekontor, PNE, EverYield, Multitude, Singulus, Eleving, Score Capital, Formycon, LAIQON, ABO Energy, BENO, … erschien zuerst auf Anleihen-Finder.de....
|
|
|
|
|
10.08.26 - 14:03
|
Alvotech to Report Financial Results for H1 2026 (GlobeNewswire EN)
|
|
|
REYKJAVIK, ICELAND (August 10, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it will release its financial results for the first half of 2026 on Wednesday, August 19, 2026, after the U.S. market close....
|
|
|
04.08.26 - 18:36
|
Börsenradio Schlussbericht, Di., 04.08.26: DAX-Rekord (26.246 Punkte), KI-Rally, Zahlenflut, Palantier +20%. technotrans, Amadus (BRN)
|
|
|
Der DAX bleibt im Rekordmodus: Der Leitindex schließt mit einem Plus von 0,87 % bei 26.226,74 Punkten und markiert bei rund 26.246 Punkten eine neue Bestmarke. Rückenwind liefern Techwerte, Bayer und fallende Ölpreise. An der Wall Street springt Palantir nach starken Zahlen um mehr als 20 %, und auch Halbleiterwerte ziehen an. Continental steigert das bereinigte EBIT um 35,1 % auf 570 Mio. Euro. Bei Lufthansa bricht das bereinigte EBIT wegen hoher Kerosinkosten und Streiks um 56 % auf 383 Mio. Euro ein. Bayer übertrifft mit einem EBITDA von 2,144 Mrd. Euro die Erwartungen. Außerdem: Volvo leidet unter dem schwachen China-Geschäft, Spotify erreicht 300 Mio. Premium-Abos, Pfizer hebt die Umsatzprognose an, Zalando fällt trotz Wachstum deutlich und HSBC meldet einen Vorsteuergewinn von 19,5 Mrd. USD. Exklusiv im Interview: technotrans und Amadeus Fire. Börsenweisheit: "Wissen Sie, was Sie besitzen, und warum Sie es besitzen." - Peter Lynch...
|
|
|
|
|
04.08.26 - 09:06
|
Sorgt AMD für noch mehr KI-Optimismus? (MarktEinblicke)
|
|
|
Am Dienstag blicken Anleger auf die Zahlen bei Caterpillar, McDonald's, Merck, Spotify, AMD, Amgen, Booking, Gilead, Lattice Semiconductor, und Pinterest.
The post Sorgt AMD für noch mehr KI-Optimismus? first appeared on marktEINBLICKE....
|
|
|
|
|
29.07.26 - 15:39
|
Alvotech announces successful closure of FDA inspection of manufacturing facility (GlobeNewswire EN)
|
|
|
REYKJAVIK, ICELAND (July 29, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S Food and Drug Administration (FDA) has closed its inspection of the company's manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI)....
|
|
|
20.07.26 - 14:33
|
Auna Announces Reporting Dates for Second Quarter 2026 Financial Results (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Second Quarter 2026 financial results.
Earnings Release
Tuesday, August 18, 2026
Time: After Market Close
Conference Call
Wednesday, August 19, 2026
Time: 8:00 a.m. ET
Quiet Period
Monday, August 3 through Tuesday August 18, 2026
To participate, please dial
+1 888 596 4144 (Toll-Free)
+1 646 968 2525 (International)
Entry Passcode: 3884034
Webcast: click here
About Auna
Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest ...
|
|
|
20.07.26 - 11:36
|
Tonies, Idorsia, Callaway. wikifolio -Trader Marco Schai: "Der Trend ist bei der Momentum-Strategie mein Freund" (BRN)
|
|
|
wikifolio Trader Marco Schai stellt sein wikifolio "Refresh" mit knapp 200 Werten ( https://go.brn-ag.de/266 ) und seine kurzfristig ausgerichtete Trading-Strategie vor, bei der er nach Sondersituationen und Übernahmegerüchten sucht. Er erläutert außerdem, dass die schwächere Performance vor allem mit seinem Fokus auf deutsche Nebenwerte und kleinere US-Werte zusammenhängt. Idorsia ist ein Schweizer biopharmazeutisches Unternehmen. "Es wurde ein neuer Darlehensvertrag mit Pharmakon über 250 Mio. Franken abgeschlossen. Damit ist die Finanzierung für die nächsten Monate gesichert." Die Tonies SE mausert sich auch dank internationaler Expansion zu einer "soliden Anlage für unser Musterdepot". Auch Callaway Golf gehört zur Momentum-Strategie von "Refresh": "Da kaufe ich jeweils Aktien, die seit 52 Wochen um mindestens 75 % gestiegen sind und auch positive Quartalszahlen berichtet, also positiv überrascht haben. Der Trend ist bei der Momentum-Strategie mein Freund."...
|
|
|
|
|
03.07.26 - 22:03
|
Transactions of Managers and Closely Associated Persons (GlobeNewswire EN)
|
|
|
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the pledging of (i) 88,940,619 shares and (ii) 7,007,321 depository receipts on shares in Alvotech by Celtic Lux Holdings S.a. r.l. (formerly known as Alvogen Lux Holdings S.a. r.l.). The date of the transactions was June 26, 2026....
|
|
|
|
|
|
|
|
|
23.06.26 - 00:51
|
Transactions of Managers and Closely Associated Persons (GlobeNewswire EN)
|
|
|
Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 10,133,333 shares in Alvotech by Celtic Lux Holdings S.a. r.l. (formerly known as Alvogen Lux Holdings S.a. r.l.) at a price of USD 3.75 per share. The date of the transaction was June 16, 2026. ...
|
|
|
|
|
18.06.26 - 11:54
|
Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement (GlobeNewswire EN)
|
|
|
REYKJAVIK, Iceland, June 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were offered by Alvotech. Before deducting the underwriting discounts and commissions and offering expenses, the aggregate gross proceeds to the Company were approximately $98 million....
|
|
|
18.06.26 - 10:03
|
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares (GlobeNewswire EN)
|
|
|
REYKJAVIK, Iceland, June 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has commenced an underwritten public offering of its ordinary shares (the “Offering”). In addition, Alvotech expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the ordinary shares sold in the public offering at the public offering price, less underwriting discounts and commissions. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering. All of the shares in the Offering are to be issued and sold by Alvotech....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
